| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgment of reviewers 2004
|
|
|
2004
|
22 |
6 |
p. 505-
1 p.
|
artikel
|
| 2 |
A prospective study of plasma selenium levels and prostate cancer risk
|
Carroll, Peter R.
|
|
2004
|
22 |
6 |
p. 496-497
2 p.
|
artikel
|
| 3 |
Author/title index
|
|
|
2004
|
22 |
6 |
p. 506-515
10 p.
|
artikel
|
| 4 |
Chromophobe renal cell carcinoma showing oncocytoma-like hyalinized and edematous stroma: A case report and review of the literature
|
Sakai, Yu
|
|
2004
|
22 |
6 |
p. 461-464
4 p.
|
artikel
|
| 5 |
Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: A theory of pathogenesis
|
Khaled, Hussein Mostafa
|
|
2004
|
22 |
6 |
p. 443-447
5 p.
|
artikel
|
| 6 |
Cisplatin inhibits the expression of X-linked inhibitor of apoptosis protein in human LNCaP cells
|
Nomura, Takeo
|
|
2004
|
22 |
6 |
p. 453-460
8 p.
|
artikel
|
| 7 |
Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 496-
1 p.
|
artikel
|
| 8 |
Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization
|
Aly, Magdy Sayed
|
|
2004
|
22 |
6 |
p. 448-452
5 p.
|
artikel
|
| 9 |
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population
|
Carroll, Peter R.
|
|
2004
|
22 |
6 |
p. 497-498
2 p.
|
artikel
|
| 10 |
Editorial board
|
|
|
2004
|
22 |
6 |
p. iii-
1 p.
|
artikel
|
| 11 |
Improving overall men’s health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease
|
Moyad, Mark A.
|
|
2004
|
22 |
6 |
p. 485-489
5 p.
|
artikel
|
| 12 |
Information for authors
|
|
|
2004
|
22 |
6 |
p. IBC-
1 p.
|
artikel
|
| 13 |
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 503-504
2 p.
|
artikel
|
| 14 |
Long-term follow-up of radiotherapy for prostate cancer
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 494-
1 p.
|
artikel
|
| 15 |
Masthead/Subscription info (update)
|
|
|
2004
|
22 |
6 |
p. iv-
1 p.
|
artikel
|
| 16 |
Natural history of early, localized prostate cancer
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 493-494
2 p.
|
artikel
|
| 17 |
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 503-
1 p.
|
artikel
|
| 18 |
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 501-
1 p.
|
artikel
|
| 19 |
Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 501-502
2 p.
|
artikel
|
| 20 |
Phase I trial of yttrium-90—labeled anti—prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer
|
Carroll, Peter R.
|
|
2004
|
22 |
6 |
p. 499-500
2 p.
|
artikel
|
| 21 |
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 500-501
2 p.
|
artikel
|
| 22 |
Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 495-
1 p.
|
artikel
|
| 23 |
Prevalence of prostate cancer among men with a prostate-specific antigen level ⩽4.0 ng per milliliter
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 493-
1 p.
|
artikel
|
| 24 |
Preventive medicine and men’s health in urologic oncology: Part I
|
Moyad, Mark A.
|
|
2004
|
22 |
6 |
p. 465-
1 p.
|
artikel
|
| 25 |
Proton therapy for prostate cancer: The initial Loma Linda University experience
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 494-495
2 p.
|
artikel
|
| 26 |
Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration
|
Carroll, Peter R.
|
|
2004
|
22 |
6 |
p. 498-
1 p.
|
artikel
|
| 27 |
Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?
|
Smith Jr., Joseph A.
|
|
2004
|
22 |
6 |
p. 495-496
2 p.
|
artikel
|
| 28 |
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer
|
Chatta, Gurkamal
|
|
2004
|
22 |
6 |
p. 502-503
2 p.
|
artikel
|
| 29 |
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
|
Carroll, Peter R.
|
|
2004
|
22 |
6 |
p. 498-499
2 p.
|
artikel
|
| 30 |
Society of Urologic Oncology 2003 winter meeting
|
Gong, Michael C.
|
|
2004
|
22 |
6 |
p. 490-491
2 p.
|
artikel
|
| 31 |
Subject index
|
|
|
2004
|
22 |
6 |
p. 516-522
7 p.
|
artikel
|
| 32 |
Survey section ed board
|
|
|
2004
|
22 |
6 |
p. 492-
1 p.
|
artikel
|
| 33 |
Table of contents
|
|
|
2004
|
22 |
6 |
p. vii-viii
nvt p.
|
artikel
|
| 34 |
The association between obesity and the progression of prostate and renal cell carcinoma
|
Amling, Christopher L.
|
|
2004
|
22 |
6 |
p. 478-484
7 p.
|
artikel
|
| 35 |
Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part I
|
Moyad, Mark A.
|
|
2004
|
22 |
6 |
p. 466-471
6 p.
|
artikel
|
| 36 |
Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part II
|
Moyad, Mark A.
|
|
2004
|
22 |
6 |
p. 472-477
6 p.
|
artikel
|
Tijdschrift beschrijving